San Ysidro Health Running DRES-POCAI RCT — 848 Patients, EyeArt Point-of-Care AI for Diabetic Retinopathy at CA FQHC
San Ysidro Health (San Diego CA FQHC) is running the most rigorous CA FQHC-based AI diabetic retinopathy trial currently underway. DRES-POCAI (Diabetic Retinopathy Screening with Point-of-Care AI) RCT: 848 patients across 2 FQHC sites, EyeArt-based point-of-care AI integrated with EHR.
Primary outcome: DR screening completion at 90 days. Funded by Gordon and Betty Moore Foundation + Kaiser Permanente AIM-HI. ClinicalTrials.gov NCT06721351. Trial protocol published in JAMA Network Open.
This positions San Ysidro Health as a national leader in FQHC AI vision deployment. Outcomes will inform NACHC/AOA/CHCF policy recommendations on autonomous AI DR screening reimbursement and FQHC capital deployment priorities.
Primary source
JAMA Network OpenSource packet
This story's primary source + 4 related tracked stories with theirs — one print-ready digest for your team or board packet.
Free — subscribes you to the weekly Intel Brief. Individual sources are always clickable above, no email needed.
Affected FQHCs
FQHC Talent. (2026, January 15). San Ysidro Health Running DRES-POCAI RCT — 848 Patients, EyeArt Point-of-Care AI for Diabetic Retinopathy at CA FQHC. Primary source: JAMA Network Open. Retrieved July 30, 2026, from https://www.fqhctalent.com/intel/san-ysidro-health-dres-pocai-rct-2026
More in Strategy & Tactics
Jul 16
Mountain Valleys posts Saturday walk-in access at rural Fall River Valley Health Center
Jul 16
CommuniCare+OLE posts 9 p.m. perinatal and integrated-care hours plus evening dental access at Salud Clinic
Jul 13
TMHP Moves Five More Texas Medicaid Applications to IAMOnline on August 3 — Provider Access Owners Need a Release-3 Cutover Check
Jul 3
TMHP Moves LTC, EVV and Care Forms Applications to IAMOnline With MFA on August 24